Not Just For The Sick One of the most common misconceptions I hear is that trials are only for people who are seriously ill. In reality, healthy volunteers play a critical role in clinical ...

Clinical Trials of Budoprutug in Immune Thrombocytopenia (ITP) and Systemic Lupus Erythematosus (SLE) Underway; Trial of Budoprutug in Primary Membranous Nephropathy (pMN) Expected to Initiate in the ...

Breaking Down the Clinical Trial Process Clinical trials are the backbone of modern oncology, often determining the most effective primary treatment for various types of cancer. They’re the ...

Artificial intelligence (AI) in clinical research has the potential to accelerate patient access to new treatments by ...

So far this year, we have witnessed several announcements that could have a major impact on the clinical trials market and ...

The Company’s approach to drug development is based on more than 30 years of expertise to efficiently design and conduct clinical trials that demonstrate a positive benefit/risk relationship.

In this new role, Dr. Costa will work with the team of O’Neal clinical investigators to expand the number of potentially disease-altering clinical trials that we can offer our cancer patients, and to ...

A new drug is showing promise in treating Parkinson’s while reducing unwanted side effects. The pill, tavapadon, extended symptom relief without the adverse effects of the first line of treatment.

Consider this: Many clinical trials aren’t able to even move past the recruitment and enrollment stage. According to Deloitte, a “study on the benefits of virtual randomized clinical trials ...

Clinical Trials Have a Research Site Demand and Supply Crisis. Here is How to Solve it As demand for trial sites increases, more investigators are overburdened or experiencing burnout.

Innovative Pulmonary Solutions Inc., a company developing a catheter-based device to treat chronic obstructive pulmonary disease, said it raised a $10.6 million Series B round in March to move its ...

In this role, Dr. Hong will be the principal investigator for the organization’s gastroenterology clinical trials. Hepatitis C and inflammatory bowel disease are his primary interests. More Articles ...